Giselle V. Ripoll
B C1425FQB, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma.
Journal: Experimental and therapeutic medicine
Published: July 08, 2020
Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent.
Journal: Vitamins and hormones
Published: March 07, 2020
Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial.
Journal: Investigational new drugs
Published: January 07, 2020
Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.
Journal: Frontiers in oncology
Published: September 03, 2019
Search of vasopressin analogs with antiproliferative activity on small-cell lung cancer: drug design based on two different approaches.
Journal: Future medicinal chemistry
Published: March 29, 2018
Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer.
Journal: Cancer research and treatment
Published: January 12, 2018
Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells.
Journal: Frontiers in oncology
Published: October 31, 2016
Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.
Journal: Clinical & experimental metastasis
Published: December 29, 2015
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.
Journal: SpringerPlus
Published: August 04, 2015
The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.
Journal: International journal of oncology
Published: December 12, 2014
Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice.
Journal: Anticancer research
Published: September 10, 2014
Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cells.
Journal: Molecular medicine reports
Published: September 04, 2013
Last Updated: 09/26/2026